Lippa, Blaise S.,Wu, Xinyuan,Li, Qingyi,Wrona, Iwona,Jackson, Andrew J.,Chenard, Bertrand L.,Liu, Christopher M.,Liang, Guohua,Baevsky, Matthew F.,Earl, Richard Alan,McQueen, Lisa,Smit, Jared,Cowans,
申请号：
AU2015252007
公开号：
AU2015252007B2
申请日:
2015.04.23
申请国别(地区):
AU
年份:
2019
代理人:
摘要：
The present invention relates to compounds of the Formula (I), or a pharmaceutically acceptable salt, pharmaceutical preparation, or pharmaceutical composition thereof, and their use for the treatment of pain, inflammatory disease, neuropathy, dermatological disorders, pulmonary conditions, and cough, as well as inhibiting the Transient Receptor Potential Al ion channel (TRPA1).
